These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1419641)

  • 1. The selection of cases for randomised trials: a registry survey of concurrent trial and non-trial patients. The British Stomach Cancer Group.
    Ward LC; Fielding JW; Dunn JA; Kelly KA
    Br J Cancer; 1992 Nov; 66(5):943-50. PubMed ID: 1419641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group.
    Allum WH; Hallissey MT; Ward LC; Hockey MS
    Br J Cancer; 1989 Nov; 60(5):739-44. PubMed ID: 2508737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.
    Coombes RC; Schein PS; Chilvers CE; Wils J; Beretta G; Bliss JM; Rutten A; Amadori D; Cortes-Funes H; Villar-Grimalt A
    J Clin Oncol; 1990 Aug; 8(8):1362-9. PubMed ID: 2199622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Present status of surgical adjuvant chemotherapy of gastric cancer].
    Taguchi T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2169-72. PubMed ID: 2500066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Meta-analysis of 10 postoperative adjuvant chemotherapies for gastric cancer in CIH].
    Nakajima T; Ota K; Ishihara S; Oyama S; Nishi M; Hamashima N
    Gan To Kagaku Ryoho; 1994 Aug; 21(11):1800-5. PubMed ID: 8080299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.
    Lise M; Nitti D; Marchet A; Sahmoud T; Buyse M; Duez N; Fiorentino M; Dos Santos JG; Labianca R; Rougier P
    J Clin Oncol; 1995 Nov; 13(11):2757-63. PubMed ID: 7595735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer.
    Tsavaris N; Tentas K; Kosmidis P; Mylonakis N; Sakelaropoulos N; Kosmas C; Lisaios B; Soumilas A; Mandrekas D; Tsetis A; Klonaris C
    Chemotherapy; 1996; 42(3):220-6. PubMed ID: 8983891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric carcinoma: curative resection and adjuvant chemotherapy.
    Carrillo Hernández JF; Ernesto de Obaldía Castillo G; Ramírez Ortega C; Frías Mendivil M; Pardo M
    Arch Med Res; 1994; 25(1):29-35. PubMed ID: 8019111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Perioperative chemotherapy vs. surgery alone in resectable gastroesophageal carcinomas. Results of the MAGIC study].
    Lordick F; Siewert JR
    Chirurg; 2006 Dec; 77(12):1166-7. PubMed ID: 17091285
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adjuvant chemotherapy in gastric cancer. Experience at the National Institute of Nutrition].
    León Rodríguez E; Domínguez A
    Rev Invest Clin; 1992; 44(2):221-7. PubMed ID: 1439310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
    Choi JH; Kim YB; Lim HY; Park JS; Kim HC; Cho YK; Han SW; Kim MW; Joo HJ
    Hepatogastroenterology; 2007; 54(73):290-7. PubMed ID: 17419278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice.
    Chua YJ; Cunningham D
    Ann Surg Oncol; 2007 Oct; 14(10):2687-90. PubMed ID: 17653804
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
    J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?
    Briasoulis E; Fatouros M; Roukos DH
    Ann Surg Oncol; 2007 Oct; 14(10):2691-5. PubMed ID: 17653806
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer.
    Yu CC; Levison DA; Dunn JA; Ward LC; Demonakou M; Allum WH; Hallisey MT
    Br J Cancer; 1995 May; 71(5):1106-10. PubMed ID: 7734309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
    Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
    World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adjuvant chemotherapy in patients with radical resection of stomach cancer: 5-year results of a prospective randomized study].
    Jakesz R; Dittrich C; Funovics J; Hofbauer F; Rainer H; Reiner G; Schemper M; Schiessel R; Starlinger M
    Wien Klin Wochenschr; 1986 Dec; 98(24):824-30. PubMed ID: 3103336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.
    Ychou M; Boige V; Pignon JP; Conroy T; Bouché O; Lebreton G; Ducourtieux M; Bedenne L; Fabre JM; Saint-Aubert B; Genève J; Lasser P; Rougier P
    J Clin Oncol; 2011 May; 29(13):1715-21. PubMed ID: 21444866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Fazio N; Biffi R; Curigliano G; Lorizzo K; Zampino MG; de Braud F; Chiappa A; Roth A; Goldhirsch A
    J Natl Cancer Inst; 2007 Sep; 99(17):1345-6; author reply 1346-7. PubMed ID: 17728219
    [No Abstract]   [Full Text] [Related]  

  • 20. [An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)--a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with PSK for Gastric Cancer].
    Nakazato H; Koike A; Ichihashi H; Saji S; Danno M; Ogawa N
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2563-76. PubMed ID: 2505682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.